{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:57:40Z","timestamp":1792799860311,"version":"4.5.0"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T00:00:00Z","timestamp":1527465600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00278","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T06:18:50Z","timestamp":1528438730000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":101,"title":["Paracrine Effects of FGF23 on the Heart"],"prefix":"10.3389","volume":"9","author":[{"given":"Maren","family":"Leifheit-Nestler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.tig.2004.08.007","article-title":"Evolution of the Fgf and Fgfr gene families","volume":"20","author":"Itoh","year":"2004","journal-title":"Trends Genet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/jb\/mvq121","article-title":"Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease","volume":"149","author":"Itoh","year":"2011","journal-title":"J Biochem"},{"key":"B3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1101\/gad.277137.115","article-title":"Genetic insights into the mechanisms of Fgf signaling","volume":"30","author":"Brewer","year":"2016","journal-title":"Genes Dev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fcell.2016.00110","article-title":"Roles of FGF signals in heart development, health, and disease","volume":"4","author":"Itoh","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/0092-8674(94)90032-9","article-title":"Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation","volume":"79","author":"Spivak-Kroizman","year":"1994","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cytogfr.2005.01.008","article-title":"Structural basis for fibroblast growth factor receptor activation","volume":"16","author":"Mohammadi","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J Biol Chem"},{"key":"B9","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1128\/MCB.02249-06","article-title":"Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members","volume":"27","author":"Goetz","year":"2007","journal-title":"Mol Cell Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.neuron.2007.07.006","article-title":"Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels","volume":"55","author":"Goldfarb","year":"2007","journal-title":"Neuron"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1210\/me.2010-0142","article-title":"Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse","volume":"24","author":"Fon Tacer","year":"2010","journal-title":"Mol Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fphys.2013.00247","article-title":"Pathophysiological roles of FGF signaling in the heart","volume":"4","author":"Itoh","year":"2013","journal-title":"Front Physiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"15694","DOI":"10.1074\/jbc.M601252200","article-title":"Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family","volume":"281","author":"Zhang","year":"2006","journal-title":"J Biol Chem"},{"key":"B15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/nrm3528","article-title":"Exploring mechanisms of FGF signalling through the lens of structural biology","volume":"14","author":"Goetz","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.tcb.2014.11.003","article-title":"Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction","volume":"25","author":"Carter","year":"2015","journal-title":"Trends Cell Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5520","DOI":"10.1073\/pnas.1402218111","article-title":"Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis","volume":"111","author":"Tagliabracci","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B20","doi-asserted-by":"publisher","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","article-title":"FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1","volume":"297","author":"Gattineni","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1172\/JCI32409","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"B22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrendo.2011.218","article-title":"Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism","volume":"8","author":"Quarles","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1002\/jbmr.2527","article-title":"Experimental myocardial infarction upregulates circulating fibroblast growth factor-23","volume":"30","author":"Andrukhova","year":"2015","journal-title":"J Bone Miner Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"64649","DOI":"10.18632\/oncotarget.11623","article-title":"FGF23 promotes myocardial fibrosis in mice through activation of beta-catenin","volume":"7","author":"Hao","year":"2016","journal-title":"Oncotarget"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/ndt\/gfv421","article-title":"Induction of cardiac FGF23\/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease","volume":"31","author":"Leifheit-Nestler","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/ndt\/gfw454","article-title":"Vitamin D treatment attenuates cardiac FGF23\/FGFR4 signaling and hypertrophy in uremic rats","volume":"32","author":"Leifheit-Nestler","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00123","article-title":"Hepatic production of fibroblast growth factor 23 in autosomal dominant polycystic kidney disease","author":"Bienaime","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e70775","DOI":"10.1371\/journal.pone.0070775","article-title":"Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitor","volume":"8","author":"Zanchi","year":"2013","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/ki.2013.526","article-title":"Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease","volume":"85","author":"Spichtig","year":"2014","journal-title":"Kidney Int"},{"key":"B30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.kint.2017.01.015","article-title":"Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia","volume":"92","author":"Mace","year":"2017","journal-title":"Kidney Int"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1038\/s41598-017-02709-w","article-title":"FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts","volume":"7","author":"Smith","year":"2017","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0191706","DOI":"10.1371\/journal.pone.0191706","article-title":"Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model","volume":"13","author":"Sugiura","year":"2018","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1056\/NEJMra0902710","article-title":"Hemodialysis","volume":"363","author":"Himmelfarb","year":"2010","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"B35","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"E863","DOI":"10.1152\/ajpendo.00596.2012","article-title":"FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy","volume":"304","author":"Touchberry","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1093\/ndt\/gfq089","article-title":"Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients","volume":"25","author":"Nasrallah","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"B40","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/ki.2010.194","article-title":"FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease","volume":"78","author":"Yilmaz","year":"2010","journal-title":"Kidney Int"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s00467-012-2224-7","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis","volume":"27","author":"Seeherunvong","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/ki.2013.3","article-title":"Fibroblast growth factor 23 is not associated with and does not induce arterial calcification","volume":"83","author":"Scialla","year":"2013","journal-title":"Kidney Int"},{"key":"B43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5414\/CN108716","article-title":"Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients","volume":"85","author":"Sarmento-Dias","year":"2016","journal-title":"Clin Nephrol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.2215\/CJN.01880213","article-title":"Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation","volume":"8","author":"Baia","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/MAJ.0b013e3181815498","article-title":"Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients","volume":"337","author":"Hsu","year":"2009","journal-title":"Am J Med Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1093\/ndt\/gfq309","article-title":"FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment","volume":"25","author":"Seiler","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/ndt\/gfq539","article-title":"Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients","volume":"26","author":"Kirkpantur","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"B49","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","article-title":"Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population","volume":"207","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study","volume":"152","author":"Parker","year":"2010","journal-title":"Ann Intern Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1093\/eurheartj\/ehr215","article-title":"The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation","volume":"32","author":"Seiler","year":"2011","journal-title":"Eur Heart J"},{"key":"B52","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ki.2012.327","article-title":"Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community","volume":"83","author":"Arnlov","year":"2013","journal-title":"Kidney Int"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00467-013-2515-7","article-title":"Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure","volume":"28","author":"Isakova","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e73184","DOI":"10.1371\/journal.pone.0073184","article-title":"Association between circulating fibroblast growth factor 23, alpha-klotho, and the left ventricular ejection fraction and left ventricular mass in cardiology inpatients","volume":"8","author":"Shibata","year":"2013","journal-title":"PLoS One"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e000584","DOI":"10.1161\/JAHA.113.000584","article-title":"Fibroblast growth factor-23 and cardiac structure and function","volume":"3","author":"Agarwal","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B56","doi-asserted-by":"publisher","first-page":"H1504","DOI":"10.1152\/ajpheart.00331.2014","article-title":"Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease","volume":"307","author":"Imazu","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1161\/CIRCHEARTFAILURE.113.000952","article-title":"Fibroblast growth factor-23 and cardiovascular disease in the general population: the multi-ethnic study of atherosclerosis","volume":"7","author":"Kestenbaum","year":"2014","journal-title":"Circ Heart Fail"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1212\/WNL.0000000000000410","article-title":"Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS)","volume":"82","author":"Wright","year":"2014","journal-title":"Neurology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jchf.2015.05.012","article-title":"Association of fibroblast growth factor-23 levels and angiotensin-converting enzyme inhibition in chronic systolic heart failure","volume":"3","author":"Wohlfahrt","year":"2015","journal-title":"JACC Heart Fail"},{"key":"B60","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/ndt\/gfv398","article-title":"Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure","volume":"31","author":"Andersen","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B61","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/STROKEAHA.115.012379","article-title":"Fibroblast growth factor 23 is associated with subclinical cerebrovascular damage: the Northern Manhattan Study","volume":"47","author":"Wright","year":"2016","journal-title":"Stroke"},{"key":"B62","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/MNH.0b013e32835422c4","article-title":"Fibroblast growth factor 23 and the heart","volume":"21","author":"Faul","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B63","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000353593","article-title":"The role of fibroblast growth factor-23 in cardiorenal syndrome","volume":"123","author":"Kovesdy","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"B64","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mce.2016.05.008","article-title":"Update on FGF23 and klotho signaling","volume":"432","author":"Erben","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/MNH.0000000000000231","article-title":"The role of fibroblast growth factor 23 and klotho in uremic cardiomyopathy","volume":"25","author":"Grabner","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B66","doi-asserted-by":"publisher","first-page":"F1168","DOI":"10.1152\/ajprenal.00606.2015","article-title":"FGF23 from bench to bedside","volume":"310","author":"Kovesdy","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1177\/0192623317737469","article-title":"Pleiotropic actions of FGF23","volume":"45","author":"Erben","year":"2017","journal-title":"Toxicol Pathol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bone.2016.10.001","article-title":"Cardiac actions of fibroblast growth factor 23","volume":"100","author":"Faul","year":"2017","journal-title":"Bone"},{"key":"B69","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00467-016-3505-3","article-title":"Extrarenal effects of FGF23","volume":"32","author":"Haffner","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1093\/ndt\/gfs259","article-title":"FGF-23: the rise of a novel cardiovascular risk marker in CKD","volume":"27","author":"Heine","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B71","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrneph.2014.49","article-title":"Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease","volume":"10","author":"Scialla","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e0156860","DOI":"10.1371\/journal.pone.0156860","article-title":"Association between FGF23, alpha-klotho, and cardiac abnormalities among patients with various chronic kidney disease stages","volume":"11","author":"Tanaka","year":"2016","journal-title":"PLoS One"},{"key":"B73","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B74","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1161\/CIRCULATIONAHA.105.590091","article-title":"Acute heart failure syndromes: current state and framework for future research","volume":"112","author":"Gheorghiade","year":"2005","journal-title":"Circulation"},{"key":"B75","doi-asserted-by":"publisher","first-page":"11298","DOI":"10.1038\/s41598-017-10140-4","article-title":"Genetic ablation of Fgf23 or klotho does not modulate experimental heart hypertrophy induced by pressure overload","volume":"7","author":"Slavic","year":"2017","journal-title":"Sci Rep"},{"key":"B76","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.bbrc.2016.01.034","article-title":"Up-regulation of FGF23 release by aldosterone","volume":"470","author":"Zhang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"B77","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1161\/CIRCRESAHA.109.207456","article-title":"Intramyocardial fibroblast myocyte communication","volume":"106","author":"Kakkar","year":"2010","journal-title":"Circ Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1172\/JCI7315","article-title":"Fibroblast growth factor-2 mediates pressure-induced hypertrophic response","volume":"104","author":"Schultz","year":"1999","journal-title":"J Clin Invest"},{"key":"B79","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.yjmcc.2006.09.002","article-title":"High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1","volume":"42","author":"Jiang","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1074\/jbc.M109.030577","article-title":"Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and klotho","volume":"285","author":"Xiao","year":"2010","journal-title":"J Biol Chem"},{"key":"B81","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/jbmr.1721","article-title":"Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23\/FGFR\/MAPK in vitro","volume":"28","author":"Xiao","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e44161","DOI":"10.1371\/journal.pone.0044161","article-title":"A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model","volume":"7","author":"Dai","year":"2012","journal-title":"PLoS One"},{"key":"B83","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1681\/ASN.2012080865","article-title":"Loss of klotho contributes to kidney injury by derepression of Wnt\/beta-catenin signaling","volume":"24","author":"Zhou","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biocel.2017.09.009","article-title":"FGF23 activates injury-primed renal fibroblasts via FGFR4-dependent signalling and enhancement of TGF-beta autoinduction","volume":"92","author":"Smith","year":"2017","journal-title":"Int J Biochem Cell Biol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/BOR.0b013e32834b3309","article-title":"beta-catenin signaling: a novel mediator of fibrosis and potential therapeutic target","volume":"23","author":"Lam","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"B86","doi-asserted-by":"crossref","first-page":"337","DOI":"10.33549\/physiolres.932289","article-title":"Wnt\/beta-catenin signaling: a promising new target for fibrosis diseases","volume":"61","author":"Guo","year":"2012","journal-title":"Physiol Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy006","article-title":"FGF23 is induced by activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts","author":"Leifheit-Nestler","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"B88","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2009.01.001","article-title":"Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community","volume":"205","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"key":"B89","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1365-2559.2010.03547.x","article-title":"Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma","volume":"56","author":"Voigt","year":"2010","journal-title":"Histopathology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/ndt\/gft523","article-title":"FGF23 protein expression in coronary arteries is associated with impaired kidney function","volume":"29","author":"van Venrooij","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00424-016-1858-x","article-title":"Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells","volume":"468","author":"Richter","year":"2016","journal-title":"Pflugers Arch"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1161\/CIRCULATIONAHA.114.008788","article-title":"Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling","volume":"131","author":"Frieler","year":"2015","journal-title":"Circulation"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2215\/CJN.13281211","article-title":"Fibroblast growth factor 23 and inflammation in CKD","volume":"7","author":"Munoz Mendoza","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","article-title":"Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease","volume":"90","author":"Singh","year":"2016","journal-title":"Kidney Int"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.14800\/ics.279","article-title":"Chronic sustained inflammation links to left ventricular hypertrophy and aortic valve sclerosis: a new link between S100\/RAGE and FGF23","volume":"1","author":"Yan","year":"2014","journal-title":"Inflamm Cell Signal"},{"key":"B96","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12079-012-0186-y","article-title":"Signaling network of oncostatin M pathway","volume":"7","author":"Dey","year":"2013","journal-title":"J Cell Commun Signal"},{"key":"B97","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.stem.2011.08.013","article-title":"Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling","volume":"9","author":"Kubin","year":"2011","journal-title":"Cell Stem Cell"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1006\/cyto.2000.0774","article-title":"Oncostatin M activates stat DNA binding and transcriptional activity in primary human fetal astrocytes: low- and high-passage cells have distinct patterns of stat activation","volume":"12","author":"Schaefer","year":"2000","journal-title":"Cytokine"},{"key":"B99","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1046\/j.1471-4159.2000.0750563.x","article-title":"Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1\/2 and p38","volume":"75","author":"Van Wagoner","year":"2000","journal-title":"J Neurochem"},{"key":"B100","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ajhg.2007.09.002","article-title":"Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis","volume":"82","author":"Arita","year":"2008","journal-title":"Am J Hum Genet"},{"key":"B101","doi-asserted-by":"publisher","first-page":"003","DOI":"10.4172\/2155-9880.S9-003","article-title":"Oncostatin M induces FGF23 expression in cardiomyocytes","author":"Richter","year":"2012","journal-title":"J Clin Exp Cardiolog"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.healun.2015.06.007","article-title":"The failing heart is a major source of circulating FGF23 via oncostatin M receptor activation","volume":"34","author":"Richter","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"B103","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/1873-3468.12040","article-title":"Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2 D in macrophages","volume":"590","author":"Han","year":"2016","journal-title":"FEBS Lett"},{"key":"B104","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1096\/fj.15-279943","article-title":"Enhanced FGF23 production in mice expressing PI3K-insensitive GSK3 is normalized by beta-blocker treatment","volume":"30","author":"Fajol","year":"2016","journal-title":"FASEB J"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J Clin Invest"},{"key":"B106","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/01.mnh.0000447012.98357.da","article-title":"Anti-fibroblast growth factor 23 antibody therapy","volume":"23","author":"Fukumoto","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.tips.2016.10.003","article-title":"Therapeutics targeting FGF signaling network in human diseases","volume":"37","author":"Katoh","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1016\/j.jacc.2014.03.026","article-title":"Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease","volume":"63","author":"Udell","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijcard.2017.10.010","article-title":"Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure","volume":"253","author":"Ter Maaten","year":"2018","journal-title":"Int J Cardiol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1053\/j.ajkd.2014.07.022","article-title":"Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade","volume":"65","author":"Humalda","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B111","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/01.mnh.0000447020.74593.6f","article-title":"Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease","volume":"23","author":"Wolf","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B112","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1681\/ASN.2014090947","article-title":"Normal 25-hydroxyvitamin D levels are associated with less proteinuria and attenuate renal failure progression in children with CKD","volume":"27","author":"Shroff","year":"2016","journal-title":"J Am Soc Nephrol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00278\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T06:57:05Z","timestamp":1604386625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00278\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,28]]},"references-count":112,"alternative-id":["10.3389\/fendo.2018.00278"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00278","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,28]]},"article-number":"278"}}